Kestra Private Wealth Services LLC Sells 600 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kestra Private Wealth Services LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,085 shares of the exchange traded fund’s stock after selling 600 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in SPDR S&P Biotech ETF were worth $1,629,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Kingsview Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 60.3% during the fourth quarter. Kingsview Wealth Management LLC now owns 6,350 shares of the exchange traded fund’s stock worth $572,000 after buying an additional 2,388 shares during the period. Clientfirst Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $284,000. Golden State Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Strategic Financial Concepts LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $2,447,000. Finally, Telos Capital Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 6.6% during the 4th quarter. Telos Capital Management Inc. now owns 27,816 shares of the exchange traded fund’s stock valued at $2,505,000 after buying an additional 1,710 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $89.97 on Thursday. The company has a 50 day moving average price of $92.05 and a 200-day moving average price of $96.25. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The firm has a market cap of $6.86 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.